Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
about
Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data.Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosisAssessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)Pseudomonas infection in antibody deficient patients.Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosisNormal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns.Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants.High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections.Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis.Vancomycin-Resistant Pseudomonas Aeroginosa in the Cases of Trauma.A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence.Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosisExercise oxidative skeletal muscle metabolism in adolescents with cystic fibrosis.Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacinVisualizing Antimicrobials in Bacterial Biofilms: Three-Dimensional Biochemical Imaging Using TOF-SIMS.Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Cystic fibrosis in Austria.Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia.Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional StudyMolecular identification and genotyping of Pseudomonas aeruginosa isolated from cystic fibrosis and non-cystic fibrosis patients with bronchiectasis.Does a single Pseudomonas aeruginosa isolation predict COPD mortality?Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study.Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides.DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.The Role of Pseudomonas aeruginosa ExoY in an Acute Mouse Lung Infection Model.Synthesis, Structural Elucidation, and Antibacterial Evaluation of Some New Molecules Derived from Coumarin, 1,3,4-Oxadiazole, and Acetamide
P2860
Q31131422-1B2AAC5A-BF59-44C5-BB6B-08607E9B824FQ33810871-5E494D62-DC0B-4FAF-9346-42952C1A1F3FQ34278502-4E23F1BF-291D-4C6C-B2CF-D36310F84AC5Q34743061-311149B6-CACC-48B7-9817-16D82F06B499Q35023645-560FE802-A2C1-42F5-A0A4-FEE2F6DCCA0BQ35193295-8F7D3C6F-0985-4F11-A89C-0D25255D504CQ35814946-DB60005F-C44A-4D5A-95A1-979C241E2655Q36103978-5BDFC9BA-5AC8-4224-ADE1-08F539942165Q36270239-9FCEB8D3-45BF-47CC-B3BD-CD9747583C10Q36373272-6B0FBDC0-7732-4188-8612-4038CE3E5395Q36654697-8F0E7F31-2A36-437A-BCD5-AB3ACF699180Q36668852-EF4D97A0-2B74-4B4E-BB50-9A6024F3E3EAQ36944153-0B1F50CA-8EF7-4A5F-9DB0-EFD2165316FBQ36968540-1F85F32D-1E2B-413C-AB4C-0E8892DD628FQ37048071-22753EC5-23BD-458E-9E1B-B35B7AE9D4CBQ38634682-E3009B7B-E3D8-4EE3-B411-65614F9D4117Q38651755-585CE199-F8F2-4D96-88C8-7CC783772BCCQ38749090-39CF9AD8-B75E-494F-BA5C-CFCA0CD2701AQ38943041-A49CCD4B-F68A-4277-BC16-2BBE401943ADQ39571511-6BFC1953-FB4C-442E-B7A8-57035D7D21B0Q40062783-C518FEC7-379A-40ED-88F0-97DD2519DC12Q40504881-A2F67AD9-A6C2-414A-8F0F-8834EF4ED356Q40624144-FC9C7EDA-A355-470D-A767-852655E57379Q40964077-EF357153-D33C-4DCB-B2A6-D336076637DCQ41096059-1BD207B1-81C3-47E5-B49D-9E5C4FE4A6F6Q41461270-541F83FE-1455-49BF-91E9-FACE4769108FQ42852572-F15812DD-9EFF-4A4F-A8BD-FD4915EC75D1Q47155202-C8FF1205-5BA8-4E2A-ADD5-08D77A164D0AQ47169985-767E8435-C230-4196-A09A-689C64BBBAA1Q47720458-EBE0D0FA-FB01-4592-84E8-14384035D4CEQ48358705-312A019D-B2CB-4C32-BEC1-A3A7FDB6282EQ51428010-F2200DEC-136C-4B96-BBD8-3BABF3059D84Q54219142-7B929558-BEBD-44B0-9D49-F9056DF3BCECQ59141407-DFA5A914-60C0-4E2F-AA29-001F863178E1
P2860
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
@en
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
@nl
type
label
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
@en
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
@nl
prefLabel
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
@en
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.
@nl
P2093
P1476
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report
@en
P2093
H Kollberg
T Pressler
P356
10.1016/S1569-1993(11)60011-8
P478
10 Suppl 2
P50
P577
2011-06-01T00:00:00Z